Clustering of sebaceous gland carcinoma, papillary thyroid carcinoma and breast cancer in a woman as a new cancer susceptibility disorder: A case report

Journal of Medical Case Reports

Volumn 3, Issue , 2009, Pages

  Newman, Brian D ^a,b   Maher, Joseph F ^c   Subauste, Jose S ^a,d   Uwaifo, Gabriel I ^a,d   Bigler, Steven A ^a   Koch, Christian A ^a,d  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ADULT; ARTICLE; BREAST CANCER; CASE REPORT; COLONOSCOPY; ECHOGRAPHY; EYE SURGERY; EYELID CARCINOMA; FAMILY HISTORY; FEMALE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOHISTOCHEMISTRY; LOBECTOMY; MASTECTOMY; MENOPAUSE; MICROSATELLITE INSTABILITY; OSTEOPENIA; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOFREQUENCY ABLATION; SEBACEOUS CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

EID: 72449166471     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.4076/1752-1947-3-6905     Document Type: Article

References (38)

1. Large genomic deletions in AIP in pituitary adenoma predisposition. M Georgitsi E Heliovaara R Paschke, et al. J Clin Endocrinol Metab 2008 93 4146 4151 10.1210/jc.2008-1003 18628514
2. Molecular pathogenesis of MEN2-associated tumors. CA Koch, Fam Cancer 2005 4 3 7 10.1007/s10689-004-7022-3 15883703
3. Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases. H Demirci CC Nelson CL Shields RC Eagle Jr JA Shields, Ophthal Plast Reconstr Surg 2007 23 77 79 10.1097/IOP.0b013e31802c7e45 17237705
4. Sebaceous Carcinoma of the Eyelids: Personal Experience with 60 Cases. JA Shields H Demirci BP Marr RC Eagle Jr CL Shields, Ophthalmology 2004 111 2151 2157 10.1016/j.ophtha.2004.07.031 15582067
5. Sebaceous carcinoma of the ocular adnexa. LG Kass A Hornblass, Surv Ophthalmol 1989 33 477 490 10.1016/0039-6257(89)90049-0 2658172
6. Outcome with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. AN Chao Cl Shields H Krema JA Shields, Ophthalmology 2001 108 1877 1883 10.1016/S0161-6420(01)00719-9 11581065
7. Sebaceous gland tumors and systemic disease: a clinicopathologic analysis. MC Finan SM Connolly, Medicine 1984 63 63 70 10.1097/00005792- 198407000-00005 6738344
8. Papillary thyroid carcinoma. ID Hay, Endocrinol Metab Clin North Am 1990 19 545 576 2261906
9. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. ID Hay ME Hutchinson T Gonzales-Losada B McIver ME Reinalda CS Grant GB Thompson TJ Sebo JR Goellner, Surgery 2008 144 980 987 10.1016/j.surg.2008.08.035 19041007
10. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. ID Hay GB Thompson CS Grant EJ Bergstralh CE Dvorak GA Gorman MS Maurer B McIver BP Mullan AL Oberg CC Powell JA van Heerden JR Goellner, World J Surg 2002 26 879 885 10.1007/s00268-002-6612-1 12016468
11. Thyroid carcinoma: molecular pathways and therapeutic targets. YE Nikiforov, Mod Pathol 2008 21 37 S43 10.1038/modpathol.2008.10 18437172
12. The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management. CA Koch NJ Sarlis, J Endocrinol Invest 2001 24 659 675 11716153
13. Update on the Molecular Diagnosis of Endocrine Tumors: Toward -omics-Based Personalized Healthcare? F Weber C Eng, J Clin Endocrinol Metab 2008 93 1097 1104 10.1210/jc.2008-0212 18390809
14. Breast cancer susceptibility: current knowledge and implications for genetic counseling. T Rippberger D Gadzicki A Meindl B Schlegelberger, Eur J Hum Genet 2008 17 722 731 10.1038/ejhg.2008.212 19092773
15. Association of splicing defects in PTEN leading to exon skipping or partial intron RETention in Cowden syndrome. JT Celebi M Wanner Xl Ping, et al. Hum Genet 2000 107 234 238 10.1007/s004390000362 11071384
16. Sebaceous carcinoma of the breast in a patient with Muir-Torre syndrome. PA Propeck T Warner KA Scanlan, AJR 2000 174 541 542 10658739
17. Germline mutation screening of the STK11/LKB1 gene in familial breast cancer with LOH on 19p. J Chen A Lindblom, Clin Genet 2000 57 394 397 10.1034/j.1399-0004.2000.570511.x 10852375
18. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre Syndrome. MM Entius JJ Keller P Drillenburg, et al. Colon Cancer Res 2000 6 1784 1789 10815898
19. Microsatellite instability in Muir-Torre syndrome. R Honchel KC Halling DJ Schaid, Cancer Res 1994 54 1159 1163 8118799
20. Muir-Torre syndrome: a case of this uncommon entity. A Weinstein K Nouri S Bassiri-Tehrani G Jimenez, Int J Dermatol 2006 45 311 313 10.1111/j.1365-4632. 2006.01797.x 16533237
21. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. G Ponti M Ponz de Leon M Pedroni, et al. Clin Genet 2005 68 442 447 10.1111/j.1399-0004.2005.00519.x 16207212
22. A possible new syndrome with growth-hormone secRETing pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familiar testicular germ cell malignancy: A case report. M Phoung L Korde J Kramer, et al. J Med Case Rep 2007 1 9 10.1186/1752-1947-1-9 17411461
23. Contribution of PTEN large rearrangements in Cowden disease: a MAPH screening approach. F Chibon C Primois JM Bressieux D Lacombe C Lok L Mauriac A Taieb M Longy, J Med Genet 2008 45 657 65 10.1136/jmg.2008.058131 18456716
24. Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma. KM Zbuk A Patocs A Shealy H Sylvester S Miesfeldt C Eng, Nat Clin Pract Oncol 2007 4 608 612 10.1038/ncponc0935 17898811
25. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Ni KM Zbuk T Sadler A Patocs G Lobo E Edelman P Platzer MS Orloff KA Waite C Eng, Am J Hum Genet 2008 83 261 268 10.1016/j.ajhg.2008.07.011 18678321
26. Multiple tumors in a child with germline mutations in TP53 and PTEN. SE Plon ML Pirics J Nuchtern J Hicks H Russel S Agrawal K Zbuk C Eng M Hegde EPH Chin, N Engl J Med 2008 359 537 539 10.1056/NEJMc0800627 18669439
27. Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia. IJ Frew A Minola S Georgiev M Hitz H Moch S Richard AO Vortmeyer W Krek, Mol Cell Biol 2008 28 4536 4548 10.1128/MCB.02132-07 18474617
28. Papillary thyroid carcinoma and familial adenommatous polyposis of the colon. KA Donnellan SA Bigler RO Wein, Am J Otolaryngol 2009 30 58 60 10.1016/j.amjoto.2008.01.001 19027515
29. Do single nucleotide polymorphisms in the AIP gene and MEN 1 gene predispose individuals to the development of familial isolated pituitary tumors? S Ahmad LA Aaltonen M Georgitsi A Parent J Fratkin EP Gomez-Sanchez CA Koch, Exp Clin Endocrinol Diabetes 2007 115 35 S36 10.1055/s-2007-972334
30. Novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in a boy with malignant paraganglioma in a family with non-classical congenital adrenal hyperplasia. CA Koch CA Friedrich S Majumdar JD Fraktin GW Moll, Exp Clin Endocrinol Diabetes 2007 115 39 10.1055/s-2007-972346
31. Somatic VHL gene alterations in MEN 2-associated medullary thyroid carcinoma. CA Koch FM Brouwers AO Vortmeyer A Tannapfel SK Libutti Z Zhuang K Pacak HPH Neumann R Paschke, BMC Cancer 2006 6 131 10.1186/1471-2407-6-131 16707008
32. Somatic VHL gene deletion and point mutation in MEN 2A-related pheochromocytoma. CA Koch SC Huang Z Zhuang C Stolle N Azumi GP Chrousos AO Vortmeyer K Pacak, Oncogene 2002 21 479 482 10.1038/sj.onc.1205133 11821960
33. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines. TI Orban E Olah, Biochem Biophys Res Commun 2001 280 32 38 10.1006/bbrc.2000.4068 11162473
34. A novel presenilin-2 splice varian in human Alzheimer's disease brain tissue. N Sato O Hori I Yamaguchi JC Lambert, et al. J Neurochem 1999 72 2498 2505 10.1046/j.1471-4159.1999.0722498.x 10349860
35. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. L Vijayakrishnan JM Slavik Z Illes, et al. Immunity 2004 20 563 575 10.1016/S1074-7613(04)00110-4 15142525
36. Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines. MW Weng JC Lai CP Hsu, et al. Environ Mol Mutagen 2005 46 1 11 10.1002/em.20118 15714438
37. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. G Rohaly J Chemnitz S Dehde, et al. Cell 2005 122 21 32 10.1016/j.cell.2005.04.032 16009130
38. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. S Agrawal C Eng, Hum Mol Genet 2006 15 777 787 10.1093/hmg/ddi492 16436456